ADAURA EGFR NSCLC adjuvant chemotherapy early stages neoadjuvant resected lung cancer targeted therapy tyrosine kinase inhibitors

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
30 Apr 2022
Historique:
received: 07 04 2022
revised: 23 04 2022
accepted: 27 04 2022
entrez: 14 5 2022
pubmed: 15 5 2022
medline: 15 5 2022
Statut: epublish

Résumé

The ADAURA trial has been significant for the perception of

Identifiants

pubmed: 35565386
pii: cancers14092257
doi: 10.3390/cancers14092257
pmc: PMC9099844
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Références

Oncologist. 2022 May 6;27(5):407-413
pubmed: 35285487
J Clin Oncol. 2015 Jun 10;33(17):1958-65
pubmed: 25897154
Transl Lung Cancer Res. 2021 Jun;10(6):2715-2732
pubmed: 34295672
Thorac Cancer. 2021 Apr;12(7):1084-1095
pubmed: 33660941
Lancet Respir Med. 2018 Nov;6(11):863-873
pubmed: 30150014
Lung Cancer. 2019 Nov;137:7-13
pubmed: 31520922
J Hematol Oncol. 2015 May 17;8:54
pubmed: 25981169
J Clin Oncol. 2008 Jul 20;26(21):3552-9
pubmed: 18506026
J Clin Oncol. 2020 Feb 10;38(5):488-495
pubmed: 31825714
Ann Surg Oncol. 2014 Jun;21(6):2091-6
pubmed: 24585406
Thorac Surg Clin. 2012 May;22(2):227-37
pubmed: 22520290
Lung Cancer. 2017 Jul;109:137-144
pubmed: 28577943
Am J Clin Oncol. 2019 May;42(5):440-445
pubmed: 30913091
J Clin Oncol. 2019 Sep 1;37(25):2235-2245
pubmed: 31194613
Onco Targets Ther. 2018 Oct 11;11:6803-6810
pubmed: 30349313
Crit Rev Oncol Hematol. 2021 Apr;160:103305
pubmed: 33757838
Clin Cancer Res. 2021 Dec 15;27(24):6638-6643
pubmed: 34301748
PLoS One. 2015 Oct 16;10(10):e0140794
pubmed: 26474174
Cancer Discov. 2021 Jul;11(7):1688-1699
pubmed: 33632775
Clin Cancer Res. 2015 Dec 15;21(24):5439-44
pubmed: 26672084
Jpn J Clin Oncol. 2017 Dec 1;47(12):1112-1118
pubmed: 29136212
J Clin Oncol. 2013 Sep 20;31(27):3320-6
pubmed: 23980091
Signal Transduct Target Ther. 2019 Mar 8;4:5
pubmed: 30854234
JCO Precis Oncol. 2021 Feb 01;5:325-332
pubmed: 34151132
Transl Lung Cancer Res. 2019 Dec;8(Suppl 4):S395-S399
pubmed: 32038923
Future Oncol. 2021 Nov;17(31):4045-4055
pubmed: 34278827
Chest. 2017 Jan;151(1):193-203
pubmed: 27780786
Cancer Sci. 2016 Sep;107(9):1179-86
pubmed: 27323238
J Clin Oncol. 2021 Mar 1;39(7):713-722
pubmed: 33332190
Clin Cancer Res. 2006 Jul 15;12(14 Pt 2):4403s-4408s
pubmed: 16857818
Zhonghua Zhong Liu Za Zhi. 2018 Feb 23;40(2):133-137
pubmed: 29502374
Lancet. 2003 Jan 11;361(9352):137-9
pubmed: 12531582
Lancet Oncol. 2011 Aug;12(8):735-42
pubmed: 21783417
J Thorac Oncol. 2010 Jul;5(7):1105-6
pubmed: 20581580
J Clin Oncol. 2022 Jan 20;40(3):231-241
pubmed: 34726958
J Thorac Oncol. 2017 Apr;12(4):612-623
pubmed: 28017789
J Thorac Cardiovasc Surg. 2021 Feb;161(2):434-442.e2
pubmed: 32340810
Lancet Oncol. 2012 Jan;13(1):e23-31
pubmed: 21764376
Nat Rev Cancer. 2007 Mar;7(3):169-81
pubmed: 17318210
Lancet Respir Med. 2021 Sep;9(9):1021-1029
pubmed: 34280355
Ann Glob Health. 2019 Jan 22;85(1):
pubmed: 30741509
J Clin Oncol. 2015 Dec 1;33(34):4007-14
pubmed: 26324372
Biochim Biophys Acta. 2010 Mar;1804(3):559-66
pubmed: 20026433
Lung Cancer. 2014 Feb;83(2):231-9
pubmed: 24332320
Eur J Cancer. 2018 Mar;91:167
pubmed: 29301719
J Thorac Oncol. 2012 Dec;7(12):1815-1822
pubmed: 23154553
Anticancer Drugs. 2005 Nov;16(10):1123-8
pubmed: 16222155
Front Surg. 2021 Aug 19;8:715318
pubmed: 34490338
Annu Rev Pathol. 2011;6:49-69
pubmed: 20887192
Front Oncol. 2021 Apr 12;11:629394
pubmed: 33912453
J Thorac Oncol. 2011 Mar;6(3):569-75
pubmed: 21150674
Cancers (Basel). 2021 Sep 12;13(18):
pubmed: 34572801
Lancet. 2005 Oct 29-Nov 4;366(9496):1527-37
pubmed: 16257339
N Engl J Med. 2017 Feb 16;376(7):629-640
pubmed: 27959700
Clin Lung Cancer. 2015 Nov;16(6):e173-81
pubmed: 25958850
Lancet Oncol. 2018 Jan;19(1):139-148
pubmed: 29174310
J Thorac Oncol. 2011 Nov;6(11):1907-14
pubmed: 22005471
Chest. 2016 Jun;149(6):1384-92
pubmed: 26836897
Clin Cancer Res. 2022 Jun 1;28(11):2286-2296
pubmed: 35012927
Clin Lung Cancer. 2018 Nov;19(6):484-492
pubmed: 30369426
Future Oncol. 2022 Mar;18(9):1159-1169
pubmed: 35109665
J Thorac Cardiovasc Surg. 2019 Sep;158(3):895-907
pubmed: 31078312
J Int Med Res. 2020 Apr;48(4):300060519887275
pubmed: 31885349
Nat Commun. 2021 Nov 8;12(1):6450
pubmed: 34750392
N Engl J Med. 2020 Oct 29;383(18):1711-1723
pubmed: 32955177
J Clin Oncol. 2019 Jan 10;37(2):97-104
pubmed: 30444685
BMJ. 2019 Oct 7;367:l5460
pubmed: 31591158
Oncologist. 2021 Apr;26(4):266-268
pubmed: 33314452
Oncol Res Treat. 2021;44(6):344-353
pubmed: 33951671
Clin Cancer Res. 2011 May 15;17(10):3500-6
pubmed: 21558399
J Thorac Dis. 2017 Dec;9(12):5314-5321
pubmed: 29312741
Eur J Cardiothorac Surg. 2017 Aug 1;52(2):363-369
pubmed: 28402455
Lung Cancer. 2019 Oct;136:6-14
pubmed: 31421260

Auteurs

Xavier Cansouline (X)

Department of Thoracic Surgery, Tours University Hospital, 37170 Chambray-Lès-Tours, France.
Nutrition, Croissance et Cancer, INSERM UMR 1069, University of Tours, 37000 Tours, France.

Béatrice Lipan (B)

Department of Thoracic Surgery, Tours University Hospital, 37170 Chambray-Lès-Tours, France.

Damien Sizaret (D)

Department of Pathology, Tours University Hospital, 37170 Chambray-Lès-Tours, France.

Anne Tallet (A)

Platform of Solid Tumor Molecular Genetics, Tours University, 37000 Tours, France.

Christophe Vandier (C)

Nutrition, Croissance et Cancer, INSERM UMR 1069, University of Tours, 37000 Tours, France.

Delphine Carmier (D)

Department of Pneumology, Tours University Hospital, 37000 Tours, France.

Antoine Legras (A)

Department of Thoracic Surgery, Tours University Hospital, 37170 Chambray-Lès-Tours, France.
Nutrition, Croissance et Cancer, INSERM UMR 1069, University of Tours, 37000 Tours, France.

Classifications MeSH